Howard SC, McCormick J, Pui C-H, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21(12):1471–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist. 2006;11(6):694–703.

Article  CAS  PubMed  Google Scholar 

Pathak A, Purkayastha A, Gupta A, Guleria B, Rathore A. High Dose methotrexate in oncological practice: A review and update on recent trends in administration and management of toxicity. Acta Sci Cancer Biol. 2018;2:27–30.

Google Scholar 

Rouch JA, Burton B, Dabb A, Brown V, Seung AH, Kinsman K, et al. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate. J Oncol Pharm Pract. 2017;23(1):3–9.

Article  CAS  PubMed  Google Scholar 

Cohen B, Laish I, Brosh-Nissimov T, Hoffman A, Katz LH, Braunstein R, et al. Efficacy of urine alkalinization by oral administration of sodium bicarbonate: a prospective open-label trial. Am J Emerg Med. 2013;31(12):1703–6.

Article  PubMed  Google Scholar 

Diachinsky M, Tran T, Jupp J, McKinnon K. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience. J Oncol Pharm Pract: Off Publ Int Soc Oncol Pharm Pract. 2021;27(1):119–27.

Article  CAS  Google Scholar 

Heisler RD, Kelly JJ, Abedinzadegan Abdi S, Hawker JL, Fong LG, Quon JL, et al. Evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer. 2022;30(2):1273–81.

Article  Google Scholar 

Kintzel PE, Campbell AD, Yost KJ, Brinker BT, Arradaza NV, Frobish D, et al. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate. J Oncol Pharm Pract: Off Publ Int Soc Oncol Pharm Pract. 2012;18(2):239–44.

Article  CAS  Google Scholar 

Kramer E, Filtz M, Pace M. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate. J Oncol Pharm Pract: Off Publ Int Soc Oncol Pharm Pract. 2021;27(1):26–32.

Article  CAS  Google Scholar 

Reed DR, Pierce EJ, Sen JM, Keng MK. A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate. Cancer Manage Res. 2019;11:8065.

Article  CAS  Google Scholar 

Reed DR, Sen JM, Pierce EJ, Nicolais MC, Keng MK. Oral regimen for urine alkalization in patients receiving high dose methotrexate during a national shortage of intravenous sodium bicarbonate. Blood. 2018;132:2309.

Article  Google Scholar 

Roy AM, Lei M, Lou U. Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage. J Oncol Pharm Pract: Off Publ Int Soc Oncol Pharm Pract. 2019;25(8):1860–6.

Article  CAS  Google Scholar 

Villegas Rubio JA, Cacciavillano W, Rose A, Zubizarreta P, Scopinaro M. Ambulatory high-dose methotrexate administration in pediatric osteosarcoma patients at a single institution in Argentina. J Pediatr Hematol Oncol. 2017;39(7):e349–52.

Article  CAS  PubMed  Google Scholar 

Visage R, Kaiser N, Williams M, Kim A. Oral methods of urinary alkalinization for high-dose methotrexate administration: alternatives to intravenous sodium bicarbonate during a critical drug shortage. J Pediatr Hematol Oncol. 2019;41(5):371–5.

Article  CAS  PubMed  Google Scholar 

Whiteside H, Gandhi A, Ajebo G, Bryan LJ. When baking soda goes on shortage: urine alkalinization with acetazolamide and oral sodium bicarbonate. Ann Pharmacother. 2018;52(3):297–8.

Article  PubMed  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.

Article  PubMed  PubMed Central  Google Scholar 

Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–84.

Article  PubMed  Google Scholar 

Freites-Martinez A, Santana N, Arias-Santiago S, Viera A. Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas dermo-sifiliograficas. 2021;112(1):90–2.

Article  CAS  PubMed  Google Scholar 

Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805.

Article  PubMed  Google Scholar 

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

Article  PubMed  PubMed Central  Google Scholar 

Igelström E, Campbell M, Craig P, Katikireddi SV. Cochrane’s risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: A methodological systematic review. J Clin Epidemiol. 2021;140:22–32.

Article  PubMed  PubMed Central  Google Scholar 

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

Article  CAS  PubMed  Google Scholar 

Hedges LV, Vevea JL. Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998;3:486–504.

Article  Google Scholar 

Higgins JP, Green S (2011) Identifying and measuring heterogeneity. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 ed: Wiley

Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7(8):889–94.

Article  CAS  PubMed  Google Scholar 

Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;47:15–7.

Google Scholar 

Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. bmj. 1997;315(7109):629–34.

Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046–55.

Article  CAS  PubMed  Google Scholar 

Widemann BC, Schwartz S, Jayaprakash N, Christensen R, Pui CH, Chauhan N, et al. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy. Pharmacotherapy. 2014;34(5):427–39.

Article  CAS  PubMed  Google Scholar 

Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Cancer. 1995;76(3):521–6.

Article  CAS  PubMed  Google Scholar 

Perazella MA, Moeckel GW. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy. Semin Nephrol. 2010;30(6):570–81.

Article  CAS  PubMed  Google Scholar 

1.Sodium bicarbonate: Drug information. In: Post T, editor. UpToDate. Waltham, MA: UpToDate; 2023.

Ramsey LB, Balis FM, O’Brien MM, Schmiegelow K, Pauley JL, Bleyer A, et al. Consensus guideline for use of glucarpidase in patients with high-dose methotrexate induced acute kidney injury and delayed methotrexate clearance. Oncologist. 2018;23(1):52–61.

Article  CAS  PubMed  Google Scholar 

Gisolfi CV, Summers RW, Schedl HP, Bleiler TL, Oppliger RA. Human intestinal water absorption: direct vs. indirect measurements. Am J Physiol. 1990;258(2 Pt 1):G216-22.

CAS  PubMed  Google Scholar 

Kahle LE, Kelly PV, Eliot KA, Weiss EP. Acute sodium bicarbonate loading has negligible effects on resting and exercise blood pressure but causes gastrointestinal distress. Nutr Res (New York, NY). 2013;33(6):479–86.

Article  CAS  Google Scholar 

Carr AJ, Slater GJ, Gore CJ, Dawson B, Burke LM. Effect of sodium bicarbonate on [HCO3-], pH, and gastrointestinal symptoms. Int J Sport Nutr Exerc Metab. 2011;21(3):189–94.

Article  CAS